Triclosan: A critical review of the experimental data and development of margins of safety for consumer products

References

• Adams R, Maibach H. (1985). A five-year study of cosmetic reactions. J Am Acad Dermatol 13:1062–1069.
   PubMed Web of Science ®Google Scholar
• Adolfsson-Erici M, Pettersson M, Parkkonen J, Sturve J. (2002). Triclosan a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 46:1485–1489.
   PubMed Web of Science ®Google Scholar
• Aiello A, Larson E, Levy S. (2007). Consumer antibacterial soaps: Effective or just risky? Clin Infect Dis 45(Suppl 2):S137–S147.
   Google Scholar
• Allen B, Kavlock R, Kimmel C, Faustman E. (1994a). Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam Appl Toxicol 23:487–495.
   PubMedGoogle Scholar
• Allen B, Kavlock R, Kimmel C, Faustman E. (1994b). Dose-response assessment for developmental toxicity. III. Statistical models. Fundam Appl Toxicol 23:496–509.
   PubMedGoogle Scholar
• Allmyr M, Adolfsson-Erici M, McLachlan M, Sandborgh-Englund G. (2006). Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ 372:87–93.
   PubMed Web of Science ®Google Scholar
• Arni P, Muller D. (1978a). Salmonella/mammalian-microsome mutagenicity test with FAT 80 023/A. Ciba-Geigy Limited. Experiment no.78–2511. March 1.
   Google Scholar
• Arni P, Muller D. (1978b). Mutagenicity test on S. Cerevisiae MP-1 in vitro with FAT 80 023/A. Ciba-Geigy Limited. Experiment no. 78/3402/978. November 27.
   Google Scholar
• Arni P, Muller D. (1979). Intrasanguine host mediated assay with S. Typhimurium with FAT 80 023/A. Ciba-Geigy Limited. Experiment no. 78/2803. March 27.
   Google Scholar
• Ashby J, Brady A, Elcombe C, Elliott B, Ishmael J, Odum J, Tugwood J, Kettle S, Purchase I. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol 13(Suppl 2):S1–S117.
   Google Scholar
• Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou J, Staels B, Auwerx J, Laville M, Vidal H. (1997). Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: No alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319–1327.
   PubMed Web of Science ®Google Scholar
• Auletta C. (1995). An 18-month oral oncogenicity study of tricolsan in the mouse via dietary administration. Pharmaco LSR. Study no. 93–2260.
   Google Scholar
• Baert J, Veys R, Ampe K, De Boever J. (1996). The effect of sodium lauryl sulphate and triclosan on hamster cheek pouch mucosa. Int J Exp Pathol 77:73–78.
   PubMedGoogle Scholar
• Bagley D, Lin Y. (2000). Clinical evidence for the lack of triclosan accumulation from daily use in dentifrices. Am J Dent 13:148–152.
   PubMed Web of Science ®Google Scholar
• Barkvoll P, Rolla G. (1994). Triclosan protects the skin against dermatitis caused by sodium lauryl sulphate exposure. J Clin Periodontol 21:717–719.
   PubMed Web of Science ®Google Scholar
• Barnes E. (1991a). Mentadent P toothpaste: Background study in man; haematological and biochemical data. Environmental Safety Laboratory, Unilever Research. Study number TT881017.
   Google Scholar
• Barnes E. (1991b). Mentadent P toothpaste: Triclosan toothpaste study in man; haematological and biochemical data. Environmental Safety Laboratory, Unilever Research. Study number TT880669.
   Google Scholar
• Barnhart W, Hiller L, Leonard G, Michaels S. (1974). Dentifrice usage and ingestion among four age groups. J Dent Res 53:1317–1322.
   PubMed Web of Science ®Google Scholar
• Beiswanger B, Touchy M. (1990). Analysis of blood plasma samples for free triclosan, triclosan-glucuronide, triclosan sulfate and total triclosan from subjects using a triclosan dentifrice or a dentifrice bar soap and deodorant. OHRI study 89-A-111.
   Google Scholar
• Bendig J. (1990). Surgical hand disinfection: Comparison of 4% chlorhexidine detergent solution and 2% triclosan detergent solution. J Hosp Infect 15:143–148.
   Google Scholar
• Bentley E, Ellwood R, Davies R. (1999). Fluoride ingestion from toothpaste by young children. Br Dent J 186:460–462.
   PubMedGoogle Scholar
• Bentley P, Calder I, Elcombe C, Grasso P, Stringer D, Wiegand H. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem Toxicol 31:857–907.
   PubMed Web of Science ®Google Scholar
• Bility M, Thompson J, McKee R, David R, Butala J, Vanden Heuvel J, Peters J. (2004). Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol Sci 82:170–182.
   PubMed Web of Science ®Google Scholar
• Black J, Howes D. (1975). Percutaneous absorption of triclosan from toilet preparations. Soc Cosc Chem Great Br 26 205–215.
   Google Scholar
• Black J, Howes D, Rutherford T. (1975). Percutaneous absorption and metabolism of Irgasan DP300. Toxicology 3:33–47.
   PubMed Web of Science ®Google Scholar
• Bojes H, Thurman R. (1996). Peroxisome proliferators activate Kupffer cells in vivo. Cancer Res 56:1–4.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36:781–792.
   PubMed Web of Science ®Google Scholar
• Brady L, Thomson M, Palmer M, Harkness J. (1990). Successful control of endemic MRSA in a cardiothoracic surgical unit. Med J Aust 152:240–245.
   PubMedGoogle Scholar
• Brockman J. (1997b). Final report: Pharmacokinetic study of a triclosan dentifrice in healthy adult subjects. Hill Top Research, Ltd. HTR project no. 97-1563-70.
   Google Scholar
• Broeckx W, Blondeel A, Dooms-Goossens A, Achten G. (1987). Cosmetic intolerance. Contact Dermatitis 16:189–194.
   PubMed Web of Science ®Google Scholar
• Brooker P, Gray V, Howell A. (1988). Analysis of metaphase chromosomes obtained from CHO cells cultured in vitro and treated with triclosan. Huntingdon Research Centre. ULR 214/88731, Unilever test no. KC 880171/1988. August 11.
   Google Scholar
• Budavari S, O’Neil M, Smith A. (1989) The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. 11th ed. Rahway, NJ: Merck & Co.
   Google Scholar
• Burns J. (1996). 14-Day repeated dose dermal study of tricolsan in mice. Triclosan Industry Alliance. Corning Hazleton Incorporated Laboratory. CHV 6718–101.
   Google Scholar
• Burns J. (1997a). 14-Day repeated dose dermal study of tricolsan in CD-1 mice. Triclosan Industry Alliance. Corning Hazleton Incorporated Laboratory. CHV 2763–100.
   Google Scholar
• Burns J. (1997b). 14-Day repeated dose dermal study of tricolsan in CD-1 mice. Triclosan Industry Alliance. Corning Hazleton Incorporated Laboratory. CHV 6718–102.
   Google Scholar
• Calafat A, Ye X, Wong L, Reidy J, Needham L. (2008). Urinary concentrations of triclosan in the U.S. population: 2003–2004. Environ Health Perspect 116:303–307.
   PubMed Web of Science ®Google Scholar
• Cariello N, Romach E, Colton H, Ni H, Yoon L, Falls J, Casey W, Creech D, Anderson S, Benavides G, Hoivik D, Brown R, Miller R. (2005). Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. Toxicol Sci 88:250–264.
   PubMed Web of Science ®Google Scholar
• Cattley R. (2004). Peroxisome proliferators and receptor-mediated hepatic carcinogenesis. Toxicol Pathol 32(Suppl 2):6–11.
   Google Scholar
• Cattley R, DeLuca J, Elcombe C, Fenner-Crisp P, Lake B, Marsman D, Pastoor T, Popp J, Robinson D, Schwetz B, Tugwood J, Wahli W. (1998). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regul Toxicol Pharmacol 27(1 Pt 1):47–60.
   Google Scholar
• Caudal F, Grimault D, Sioufi A. (1974). Urinary Excretion (free and glucuronide) in man after topical application of CGP 433 cream. Ciba-Geigy.
   Google Scholar
• CDC. (2005). National Health and Nutrition Examination Survey—NHANES 2003–2004. Atlanta, GA: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/nhanes 03_04.htm. Accessed April 23, 2008.
   Google Scholar
• Chambers P. (1999). FAT 80′023/S potential tumorigenic and chronic toxicity effects in prolonged dietary administration to hamsters. Huntingdon Life Sciences Ltd.
   Google Scholar
• Chasseaud L, Allen G, Major R, Holding J, Assinder D, Greathead H. (1999). Toxicokinetics of FAT 80′023/S after prolonged dietary administration to hamsters. CBG#756972896.
   Google Scholar
• Chaung W, Mi L, Boorstein R. (1997). The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair. Nucleic Acids Res 25:992–994.
   PubMed Web of Science ®Google Scholar
• Chevalier S, Roberts R. (1998). Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: Mechanisms and lack of relevance for human health [review]. Oncol Rep 5:1319–1327.
   PubMed Web of Science ®Google Scholar
• Christian M, Hoberman A. (1992). Developmental toxicity (embryo-fetal toxicity and teratogenic potential) study of C-P sample no. 38326 administered orally via the diet to Crl:CD-1(ICR)BR presumed pregnant mice. Argus Research Laboratories. Protocol number 403–010. Sponsor’s study number 92–001.
   Google Scholar
• Cohen S. (2004). Human carcinogenic risk evaluation: An alternative approach to the two-year rodent bioassay. Toxicol Sci 80:225–229.
   PubMed Web of Science ®Google Scholar
• Cohen S, Meek M, Klaunig J, Patton D, Fenner-Crisp P. (2003). The human relevance of information on carcinogenic modes of action: Overview. Crit Rev Toxicol 33:581–589.
   PubMed Web of Science ®Google Scholar
• Coia J, Duckworth G, Edwards D, Farrington M, Fry C, Humphreys H, Mallaghan C, Tucker D. (2006). Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 63(Suppl 1):S1–S44.
   PubMed Web of Science ®Google Scholar
• Colgate-Palmolive Company. (1972). P-300 soap bar (primary irritation or sensitization and repeated insult patch test in humans). October 11.
   Google Scholar
• Crofton K, Paul K, DeVito M, Hedge J. (2007). Short-term in vivo exposure to the water contaminant triclosan: Evidence fro disruption of thyroxine. Environ Toxicol Pharmacol 24:194–197.
   PubMed Web of Science ®Google Scholar
• Dalgard D. (1979). 90-Day bathing of newborn rhesus monkeys with triclosan soap solution. Hazelton Laboratories. April 26.
   Google Scholar
• Dayan A. (2007). Risk assessment of triclosan [Irgasan] in human breast milk. Food Chem Toxicol 45:125–129.
   PubMed Web of Science ®Google Scholar
• de Groot A, Liem D, Nater J, van Ketel W. (1985). Patch tests with fragrance materials and preservatives. Contact Dermatitis 12:87–92.
   Google Scholar
• de Groot A, Weyland J, Bos J, Jagtman B. (1986). Contact allergy to preservatives (I). Contact Dermatitis 14:120–122.
   Google Scholar
• Denning H, Sliva S, Willson G. (1992). Triclosan: Effects on pregnancy and post-natal development in rats. Environmental Safety Laboratory, Unilever Research. Document reference: 92–105.
   Google Scholar
• DeSalva S, Kong B, Lin Y. (1989). Triclosan: A safety profile. Am J Dent. 2(Special No.):185–196.
   Google Scholar
• Dorner R. (1973). The systematic toxicological effects of three bacteriostats topically applied to the skin of young canines. Laboratory Research Enterprises Inc. LRE study no. 301–002.
   Google Scholar
• Doull J, Cattley R, Elcombe C, Lake B, Swenberg J, Wilkinson C, Williams G, van Gemert M. (1999). A cancer risk assessment of di(2-ethylhexyl)phthalate: Application of the new U.S. EPA Risk Assessment Guidelines. Reg Toxicol Pharmacol 29:327–357.
   PubMed Web of Science ®Google Scholar
• Drake J. (1975). 1 Year oral toxicity study in baboons with compound FAT 80 023/A. Ciba-Geigy Limited. July 26.
   Google Scholar
• Elcombe C, Odum J, Foster J, Stone S, Hasmall S, Soames A, Kimber I, Ashby J. (2002). Prediction of rodent nongenotoxic carcinogenesis: Evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. Environ Health Perspect 110:363–375.
   PubMed Web of Science ®Google Scholar
• Eldridge S. (1993). Cell proliferation in rodent liver. Final report. Pathology Associates, Inc. January 13.
   Google Scholar
• Ericsson Y, Forsman B. (1969). Fluoride retained from mouth rinses and dentifrices in preschool children. Caries Res 3:290–299.
   Google Scholar
• EU (2007). Cosmetics Directive 76/768//EEC, Annex VI, Part I, entry 25. List of Preservatives which cosmetic products may contain. Available at: http://ec.europa.eu/enterprise/cosmetics/cosing/index.cfm?fuseaction=search.results&annex=VI&search. Accessed December 3, 2009.
   Google Scholar
• Fahrig R. (1978a). Genetic activity of Irgasan DP 300 in the MP-1 strain of S. cerevisiae. June 22. Zentrallaboratorium fur mutagenate-sprufung der Deutschan Forschungs-gemeinschaf.
   Google Scholar
• Fahrig R. (1978b). The effect of Irgasan DP 300 in the “Mammalian Spot Test” an in vivo method for the detection of genetic alterations in somatic cells of mice. June 22. Zentrallaboratorium fur mutagenate-sprufung der Deutschan Forschungs-gemeinschaf.
   Google Scholar
• FDA. (1994). Topical antimicrobial drug products for over-the-counter human use: Tentative final monograph for health care antiseptic drug products. Federal Register 59:31402–31452.
   Google Scholar
• FDA. (1997). New Drug Application for Colgate Total NDA 020231. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm? fuseaction=Search. DrugDetails. Accessed December 4, 2009.
   Google Scholar
• FDA. (2006). Letter to Jay Feldman of Beyond Pesticides from Steven Galson of the Federal Drug Administration. Docket no. 2005P-0432/CP 1.
   Google Scholar
• Fishman S. (1993). Clinical effects of fluoride dentifrices on dental caries in 3000 adults. Colgate-Palmolive Company. Study number 1988-5A/DP89-001.
   Google Scholar
• Fritz H. (1971). Dominant lethal study preparation: GP 41 353. Ciba-Geigy Limited. October 20.
   Google Scholar
• Gearing K, Crickmore A, Gustafsson J. (1994). Structure of the mouse peroxisome proliferator activated receptor alpha gene. Biochem Biophys Res Commun 199:255–263.
   PubMed Web of Science ®Google Scholar
• Goldsmith L, Craig D. (1983). 90-Day oral toxicity study in rats with FAT 80′023/H. Final report. Litton Bionetics. LBI project number 22188. October.
   Google Scholar
• Habucky K. (1997a). A pilot study to determine triclosan plasma levels in humans following a single oral administration of triclosan containing products. Concordia Research Laboratories Inc. HLS study number 97–8502. May 12.
   Google Scholar
• Habucky K. (1997b). A pilot study to determine triclosan plasma levels in children following a single oral administration of a triclosan containing product. Concordia Research Laboratories Inc. HLS study number 97–8502A. July 1.
   Google Scholar
• Hall B, Tozer S, Safford B, Coroama M, Steiling W, Leneveu-Duchemin M, McNamara C, Gibney M. (2007). European consumer exposure to cosmetic products, a framework for conducting population exposure assessments. Food Chem Toxicol 45:2097–2108.
   PubMed Web of Science ®Google Scholar
• Hanefeld M, Kemmer C, Kadner E. (1983). Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46:239–246.
   PubMed Web of Science ®Google Scholar
• Hanioka N, Omae E, Nishimura T, Jinno H, Onodera S, Yoda R, Ando M. (1996). Interaction of 2,4,4′-trichloro-2′-hydroxydiphenyl ether with microsomal cytochrome P450-dependent monooxygenases in rat liver. Chemosphere 33:265–276.
   PubMed Web of Science ®Google Scholar
• Hannuksela M, Kousa M, Pirila V. (1976). Allergy to ingredients of vehicles. Contact Dermatitis 2:105–110.
   PubMedGoogle Scholar
• Hargreaves J, Ingram G, Wagg B. (1972). A gravimetric study of the ingestion of toothpaste by children. Caries Res 6:237–243.
   Google Scholar
• Heidemann A. (1990). Chromosome aberration assay in Chinese Hamster V79 cells in vitro with FAT 80′023/Q. Cytotest Cell Research. CCR project no. 179100. December 27.
   Google Scholar
• Henderson L, Proudlock R, Haynes P, Meaking K. (1988a). Triclosan mouse micronucleus test. HRC study no. ULR 213/88492. Huntingdon Research Centre. Unilever study KC 880168.
   Google Scholar
• Henderson L, Ransome S, Brabbs C, Tinner A, Davies S, Lloyd A. (1988b). An assessment of the mutagenic potential of triclosan using the mouse lymphoma TK locus assay. Huntingdon Research Centre.
   Google Scholar
• Hinton R, Mitchell F, Mann A, Chescoe D, Price S, Nunn A, Grasso P, Bridges J. (1986). Effects of phthalic acid esters on the liver and thyroid. Environ Health Perspect 70:195–210.
   PubMed Web of Science ®Google Scholar
• Hohensee G, Berke M. (1991). Final report. Concentrations of triclosan, triclosan glucuronide, and triclosan sulfate in dog plasma, urine and fecal samples. Hazelton Wisconsin, Inc. Study no. 425–015.
   Google Scholar
• Holsapple M, Pitot H, Cohen S, Boobis A, Klaunig J, Pastoor T, Dellarco V, Dragan Y. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci 89:51–56.
   PubMed Web of Science ®Google Scholar
• Hong H, Hall R, Smith N, Kurz N. (1976). Chemical analyses of hexachlorophene (HCP), tribomsalan (TBS), triclosan (DP-300), triclocarbon (TCC), and cloflucarbon (CF3) in tissues, blood and urine of animals and humans. Colgate Palmolive Company. January 26.
   Google Scholar
• Hool G, Strasser F, Muller D. (1978). Chromosome studies in male germinal epithelium, FAT 80 023/A, mouse (test for mutagenic effects on spermatogonia). Ciba-Geigy Limited. Experiment no. 78–2903/1978.
   Google Scholar
• Hool G, Strasser F, Muller D. (1979). Chromosome studies in male germinal epithelium, FAT 80 023/A mouse (test for mutagenic effects on spermatogonia). Ciba-Geigy Limited. Experiment no. 78–2904/1979.
   Google Scholar
• Howes D, Moule R, York M. (1989a). Toxicokinetics of triclosan. Part 1. Fate of triclosan in the Swiss-S mouse. Environmental Safety Laboratory, Colworth House, Sharnbrook, Bedford, MK 44 ILQ, England. No. 47890, June.
   Google Scholar
• Howes D, Moule R, York M. (1989b). Toxicokinetics of [14C] triclosan. Part 2. Fate of triclosan in the C-57 Mouse. Environmental Safety Laboratory, Colworth House, Sharnbrook, Bedford, MK 44 ILQ, England. No. 47890, June.
   Google Scholar
• Hurst C, Waxman D. (2003). Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci 74:297–308.
   PubMed Web of Science ®Google Scholar
• IARC. (1995). IARC Technical Report No. 24. Peroxisome Proliferation and Its Role in Carcinogenesis. World Health Organization: International Agency for Research on Cancer. Lyon, France: IARC Press.
   Google Scholar
• ICRP. (1975). Report of the Task Group on Reference Man. Elmsford, NY: Pergamon Press.
   Google Scholar
• IPCS. (2005). IPCS framework for analyzing the relevance of a cancer mode of action for humans. IPCS Workshop 1–29.
   Google Scholar
• Jokinen M. (1995). An 18-month oral oncogenicity study of triclosan in the mouse via dietary administration. Pathology Associates International. August 17.
   Google Scholar
• Jones E, Wilson L. (1988). Triclosan Ames metabolic activation test to assess the potential mutagenic effect. Huntingdon Research Centre, Ltd. URL 215/88704. September 9.
   Google Scholar
• Kanetoshi A, Ogawa H, Katsura E, Okui T, Kaneshima H. (1988). Disposition and excretion of Irgasan DP300 and its chlorinated derivatives in mice. Arch Environ Contam Toxicol 17:637–644.
   PubMedGoogle Scholar
• Klaunig J, Babich M, Baetcke K, Cook J, Corton J, David R, DeLuca J, Lai D, McKee R, Peters J, Roberts R, Fenner-Crisp P. (2003). PPARalpha agonist-induced rodent tumors: Modes of action and human relevance. Crit Rev Toxicol 33:655–780.
   PubMed Web of Science ®Google Scholar
• Kligman A. (1969). Phototoxicity and photoallergy study on product L-2. Report to Geigy Chemical Corporation. Hospital of the University of Pennsylvania. February 10 1969.
   Google Scholar
• Krinke G. (1973). GP 41 353: Report on the two weeks neurotoxicity study—oral administration to albino rats. Ciba-Geigy Limited. Biological Research Laboratories of the Pharmaceuticals Davison.
   Google Scholar
• Lachapelle J, Tennstedt D. (1979). Low allergenicity of triclosan. Predictive testing in guinea pigs and in humans. Dermatologica 158:379–383.
   PubMedGoogle Scholar
• Lai D. (2004). Rodent carcinogenicity of peroxisome proliferators and issues on human relevance. J Environ Sci Health 22:37–55.
   Google Scholar
• Lake B. (1995a). Peroxisome proliferation: Current mechanisms relating to nongenotoxic carcinogenesis. Toxicol Lett 82–83, 673–681.
   Google Scholar
• Lake B, Rijcken W, Gray T, Foster J, Gangolli S. (1984). Comparative studies of the hepatic effects of di- and mono-n-octyl phthalates di-(2-ethylhexyl) phthalate and clofibrate in the rat. Acta Pharmacol Toxicol (Copenh) 54:167–176.
   PubMedGoogle Scholar
• Langauer M, Muller D. (1974). Nucleus anomaly test on somatic interphase nuclei, GP 41 343 (triclosan), Chinese hamster. Ciba-Geigy Limited. May 31.
   Google Scholar
• Langauer M, Muller D. (1978). Nucleus anomaly test in somatic interphase nuclei, long-term study with FAT 80023/A, Chinese hamster. Ciba-Geigy Limited. Experiment no. 78–3005. August 23.
   Google Scholar
• Ledwith B, Johnson T, Wagner L, Pauley C, Manam S, Galloway S, Nichols W. (1996). Growth regulation by peroxisome proliferators: Opposing activities in early and late G1. Cancer Res 56:3257–3264.
   PubMed Web of Science ®Google Scholar
• Leuschner F, Leuschner A, Schwerdtfeger W, Dontenwill W. (1970a). 90 Day oral toxicity study in new Zealand white rabbits with CH 3565. Laboratorium fur Pharmakologie und Toxikologie. July 31.
   Google Scholar
• Leuschner F, Leuschner A, Schwerdtfeger W, Dontenwill W. (1970b). 90 Day oral toxicity study in beagle dogs with CH 3565. Laboratorium fur Pharmakologie und Toxikologie. July 10.
   Google Scholar
• Leutkemeier H, Ullmann L, Zak F, Sachsse K, Shess R. (1974). Irgasan DP 300 (FAT 80023/A) 21-day inhalation study on the rat. Ciba-Geigy Limited. July 24.
   Google Scholar
• Li Y, Tharappel J, Cooper S, Glenn M, Glauert H, Spear B. (2000). Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappaB. DNA Cell Biol 19:113–120.
   PubMedGoogle Scholar
• Lin Y. (1988). Triclosan dentifrice plaque clinical study. Personal communication to Dr. S. J. Salva. November 15.
   Google Scholar
• Lin Y. (1989a). Steady-state blood lead levels of triclosan (DP-300) following dentifrice and aqueous solution administration in 18 normal subjects (protocol number 87-01). Final report. Colgate-Palmolive Company. April 3.
   Google Scholar
• Lin Y. (1989b). Triclosan Canada Study. Personal communication to S. J. DeSalva. January 24.
   Google Scholar
• Lin Y. (2000). Buccal absorption of triclosan following topical mouth rinse application. Am J Dent 13:215–217.
   PubMed Web of Science ®Google Scholar
• Lin Y, Smith N. (1990). Pharmacokinetics of triclosan in rats following a single oral administration. Colgate-Palmolive Company. Research report no. 3803. March 8.
   Google Scholar
• Loretz L, Api A, Barraj L, Burdick J, Dressler W, Gettings S, Han Hsu H, Pan Y, Re T, Renskers K, Rothenstein A, Scrafford C, Sewall C. (2005). Exposure data for cosmetic products: Lipstick, body lotion, and face cream. Food Chem Toxicol 43:279–291.
   PubMed Web of Science ®Google Scholar
• Loretz L, Api A, Barraj L, Burdick J, Davis de A, Dressler W, Gilberti E, Jarrett G, Mann S, Laurie Pan Y, Re T, Renskers K, Scrafford C, Vater S. (2006). Exposure data for personal care products: Hairspray, spray perfume, liquid foundation, shampoo, body wash, and solid antiperspirant. Food Chem Toxicol 44:2008–2018.
   PubMed Web of Science ®Google Scholar
• Lucker P, Wetzelsberger N, Wieckhorst G, Sturm Y. (1990). Safety (tolerance) of pharmacokinetics of triclosan (TCS)—An expertise. Ciba-Geigy AG, Basel, Switzerland.
   Google Scholar
• Lyman F, Furia T. (1969). Toxicology of 2,4,4′-trichloro-2′-hydroxy-diphenyl ether. IMS Ind Med Surg 38:64–71.
   PubMedGoogle Scholar
• Mage D, Allen R, Gondy G, Smith W, Barr D, Needham L. (2004). Estimating pesticide dose from urinary pesticide concentration data by creatinine correction in the Third National Health and Nutrition Examination Survey (NHANES-III). J Expo Anal Environ Epidemiol 14:457–465.
   PubMedGoogle Scholar
• Magnusson J. (1979). Mutagenic effects of Irgasan on Drosophila molanogastar. University of Stockholm Wallenberg Laboratory.
   Google Scholar
• Maibach H. (1969). Percutaneous penetration of Irgasan CH 3565 in a soap solution. Department of Dermatology, University of California, Medical Center, San Francisco, California. May.
   Google Scholar
• Makowska J, Anders C, Goldfarb P, Bonner F, Gibson G. (1990). Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation. Biochem Pharmacol 40:1083–1093.
   PubMed Web of Science ®Google Scholar
• Mandard S, Muller M, Kersten S. (2004). Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61:393–416.
   PubMed Web of Science ®Google Scholar
• Marzulli F, Maibach H. (1973). Antimicrobials: Experimental contact sensitization in man. J Soc Cos Chem 24:399–421.
   Web of Science ®Google Scholar
• Maurer T, Thomann P, Weirich E, Hess R. (1979). Predictive evaluation in animals of the contact allergenic potential of medically important substances. II. Comparison of different methods of cutaneous sensitization with “weak” allergens. Contact Dermatitis 5:1–10.
   PubMed Web of Science ®Google Scholar
• McNamara C, Rohan D, Golden D, Gibney M, Hall B, Tozer S, Safford B, Coroama M, Leneveu-Duchemin M, Steiling W. (2007). Probabilistic modelling of European consumer exposure to cosmetic products. Food Chem Toxicol 45:2086–2096.
   PubMed Web of Science ®Google Scholar
• MediaMark Research Inc. (2007). Survey of the American Consumer: Double-based 2007.
   Google Scholar
• Meek M, Bucher J, Cohen S, Dellarco V, Hill R, Lehman-McKeeman L, Longfellow D, Pastoor T, Seed J, Patton D. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33:591–653.
   PubMed Web of Science ®Google Scholar
• Mitchell J, Adams R, Glendenning W, Fisher A, Kanof N, Larsen W, Maibach H, Rudner E, Schnorr W, Storrs F, Taylor J. (1982). Results of standard patch tests with substances abandoned. Contact Dermatitis 8:336–337.
   PubMed Web of Science ®Google Scholar
• Molitor E, Persohn E. (1993). The effects of FAT 80′023/Q (Irgasan DP 300) on selected biochemical and morphological liver parameters following subchronic dietary administration to male rats. Ciba-Geigy Limited. Laboratory report no. CB 92/28.
   Google Scholar
• Molitor E, Persohn E, Thomas H. (1992). The effect of FAT 80′023/Q (Irgasan DP 300) on selected biochemical and morphological liver parameters following subchronic dietary administration to male and female mice. Ciba-Geigy Limited. Laboratory report no. CB 91/18.
   Google Scholar
• Morimura K, Cheung C, Ward J, Reddy J, Gonzalez F. (2005). Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to WY-14,643-induced liver tumorigenesis. Carcinogenesis 27:1074–1080.
   Google Scholar
• Morseth S. (1988). Two-generation reproduction study in rats FAT 80′023 A. Ciba-Geigy Corporation. Hazleton Laboratories America, Inc. HLA study no. 2386–100. March 18.
   Google Scholar
• Moss T, Howes D, Williams F. (2000). Percutaneous penetration and dermal metabolism of triclosan (2,4,4′-trichloro-2′-hydroxydiphenyl ether). Food Chem Toxicol 38:361–370.
   PubMed Web of Science ®Google Scholar
• Mueller L, Strauss W. (1974). Guinea pig Buehler sensitization study compound: 1291. Toxicological Resources. Project number 2118–74.
   Google Scholar
• NIH (2007). Household Products Database. Available at: http://hpd.nlm.nih.gov/cgi-bin/household/brands?tbl=chem&id=201&query=triclosan&searchas=TblChemicals. Accessed December 4, 2009.
   Google Scholar
• Noel R, Mawdesley-Thomas L, Squires P, Street A. (1969). Irgasan DP 300 GP 41353 oral toxicity study in baboons (repeated dosage for 4 and 13 weeks). Huntingdon Research Center.
   Google Scholar
• Oliver J, Roberts R. (2002). Receptor-mediated hepatocarcinogenesis: Role of hepatocyte proliferation and apoptosis. Pharmacol Toxicol 91:1–7.
   PubMedGoogle Scholar
• Omiecinski C, Remmel R, Hosagrahara V. (1999). Concise review of the cytochrome P450s and their roles in toxicology. Toxicol Sci 48:151–156.
   PubMed Web of Science ®Google Scholar
• Palmer C, Hsu M, Griffin K, Raucy J, Johnson E. (1998). Peroxisome proliferator activated receptor-alpha expression in human liver. Mol Pharmacol 53:14–22.
   PubMed Web of Science ®Google Scholar
• Palut D, Kostka G, Wiadrowska B, Bankowski R. (2002). Effect of diclofop on the activity of some drug-metabolizing enzymes in the liver of male Wistar rats (abstract). Rocz Panstw Zakl Hig 53:1–9.
   Google Scholar
• Parkes D. (1978a). Pilot study single dose dermal absorption of triclosan in three days old rhesus monkeys, analysis of blood and soap samples. Ciba-Geigy Corporation.
   Google Scholar
• Parkes D. (1978b). Irgasan DP300 oral dose kinetic study in adult rhesus monkeys. Ciba-Geigy Corporation.
   Google Scholar
• Parkes D. (1979). Irgasan DP 300 ninety day bathing study in newborn rhesus monkeys. Final analytical report. Hazelton Laboratories. June 4.
   Google Scholar
• Paterson R. (1967). Irgasan DP 300 GP 41353 9-day oral toxicity study in dogs. Final report. Ciba-Geigy Limited. December 21.
   Google Scholar
• Paterson R. (1969). Irgasan DP 300 GP 41 353 13-week oral toxicity study in rabbits. Final report. Ciba-Geigy Limited. March 31.
   Google Scholar
• Paul K, Hedge J, DeVito M, Crofton K. (2010). Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in young Long-Evans rats.Toxicol Sci. 113(2):367–369
   Google Scholar
• Perrenoud D, Bircher A, Hunziker T, Suter H, Bruckner-Tuderman L, Stager J, Thurlimann W, Schmid P, Suard A, Hunziker N. (1994). Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Dermatitis 30:276–279.
   PubMed Web of Science ®Google Scholar
• Persohn E. (1994). FAT 80′023/Assessment of replicative DNA synthesis in the course of a 13-week oral toxicity study in the hamster. RCC project 356490. September 19.
   Google Scholar
• Persohn E, Molitor E. (1993). The effect of FAT 80′023/Q (Irgasan DP 300) on replicative DNA Synthesis in hepatocytes following dietary administration to male rats. Chemicals Division Ciba-Geigy Limited. Laboratory Report CB 92/28-2. September 17.
   Google Scholar
• Peters J, Rusyn I, Rose M, Gonzalez F, Thurman R. (2000). Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells not Kupffer cells: Implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis 21:823–826.
   PubMed Web of Science ®Google Scholar
• Piekacz H. (1978). Effects of certain preservative agents on the course of pregnancy and fetal development in experimental animals with preliminary toxicological characters. Roczn Pzh 29:469–481.
   Google Scholar
• Plezia P. (2002). A pilot study for the in vivo evaluation of the percutaneous absorption of triclosan. Arizona Clinical Research Center.
   Google Scholar
• Portier K, Tolson J, Roberts S. (2007). Body weight distributions for risk assessment. Risk Anal 27:11–26.
   Google Scholar
• Riach C. (1988). Triclosan: Assessment of genotoxicity in an unscheduled dna synthesis assay using adult rat hepatocyte primary cultures. IRI project no. 738388. Unilever study no. KU 880258. September 21.
   Google Scholar
• Roberts R, Ganey P, Ju C, Kamendulis L, Rusyn I, Klaunig J. (2007). Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96:2–15.
   PubMed Web of Science ®Google Scholar
• Rose M, Rivera C, Bradford B, Graves L, Cattley R, Schoonhoven R, Swenberg J, Thurman R. (1999). Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. Carcinogenesis 20:27–33.
   PubMed Web of Science ®Google Scholar
• Russell L, Montgomery C. (1980). Use of the mouse spot test to investigate the mutagenic potential of triclosan (Irgasan DP300). Mutat Res 79:7–12.
   PubMedGoogle Scholar
• Rusyn I, Rose M, Bojes H, Thurman R. (2000a). Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators. Antioxid Redox Signal 2:607–621.
   PubMed Web of Science ®Google Scholar
• Rusyn I, Denissenko M, Wong V, Butterworth B, Cunningham M, Upton P, Thurman R, Swenberg J. (2000b). Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. Carcinogenesis 21:2141–2145.
   PubMedGoogle Scholar
• Rusyn I, Asakura S, Pachkowski B, Bradford B, Denissenko M, Peters J, Holland S, Reddy J, Cunningham M, Swenberg J. (2004). Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res 64:1050–1057.
   PubMed Web of Science ®Google Scholar
• Rusyn I, Peters J, Cunningham M. (2006). Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol 36:459–479.
   PubMed Web of Science ®Google Scholar
• Sachesse K, Ullmann L. (1975). Skin irritation in the rabbit after single application of FAT 80 023/A. Ciba-Geigy Limited. Project number SISS 4719.
   Google Scholar
• Safford B. (1991). A critical assessment of the 65-week in-use human trial with toothpaste containing 0.2% triclosan. Environmental Safety Laboratory, Unilever Research. Document reference: D91/007.
   Google Scholar
• Sagelsdorff P, Buser G. (1995). Investigation of the binding of Irgasan DP300 to human hamster and mouse plasma proteins in vitro. Ciba-Geigy Limited. Final report no. CB95/07. July 19.
   Google Scholar
• Sandborgh-Englund G, Adolfsson-Erici M, Odham G, Ekstrand J. (2006). Pharmacokinetics of triclosan following oral ingestion in humans. J Toxicol Environ Health A 69:1861–1873.
   PubMed Web of Science ®Google Scholar
• San Sebastian J. (1993). Rat hepatocyte primary culture/DNA repair test on 39317. Pharmakon study no. PH 311-CP-001-93. Colgate-Palmolive study no. CP-93-013. June 24.
   Google Scholar
• Schenkel A, Furia T. (1965). The absorption of CH3565 through intact human skin from soap solutions. Geigy Industrial Chemicals.
   Google Scholar
• Schmid H, Dotti A, Keller B, Kouchakji G, Luetkemeir H, Wilson J, Biedermann K, Marbot H. (1994). 13-Week Toxicity Study with FAT 80′023/R in the Hamster. Final Report. Ciba-Geigy Limited. RCC Project Number 356490. October 27.
   Google Scholar
• Schnuch A, Geier J, Uter W, Frosch P. (1998). Patch testing with preservatives antimicrobials and industrial biocides. Results from a multicenter study. Br J Dermatol 138:467–476.
   PubMed Web of Science ®Google Scholar
• Schroeder R, Daly I. (1992a). A segment II teratology study in rats with Irgacare MP (C-P sample no. 38328). Bio/Dynamics. Project no. 91–3665. Colgate-Palmolive study no. 91–005. April 16.
   Google Scholar
• Schroeder R, Daly I. (1992b). A segment II teratology study in rabbits with Irgacare MP (C-P sample no. 38328). Bio/Dynamics. Project no. 91–3666. Colgate-Palmolive study no. 91–006. April 16.
   Google Scholar
• Schultz R, Yan W, Toppari J, Volkl A, Gustafsson J, Pelto-Huikko M. (1999). Expression of peroxisome proliferator-activated receptor alpha messenger ribonucleic acid and protein in human and rat testis. Endocrinology 140:2968–2975.
   PubMed Web of Science ®Google Scholar
• SDA. (2005). Exposure and risk screening methods for consumer product ingredients. Soap and Detergent Association published in Washington, D.C.
   Google Scholar
• Shaban Z, El-Shazly S, Abdelhady S, Fattouh I, Muzandu K, Ishizuka M, Kimura K, Kazusaka A, Fujita S. (2004a). Down regulation of hepatic PPARalpha function by AhR ligand. J Vet Med Sci 66:1377–1386.
   PubMed Web of Science ®Google Scholar
• Shaban Z, El-Shazly S, Ishizuka M, Kimura K, Kazusaka A, Fujita S. (2004b). PPARalpha-dependent modulation of hepatic CYP1A by clofibric acid in rats. Arch Toxicol 78:496–507.
   PubMed Web of Science ®Google Scholar
• Shaban Z, Soliman M, El-Shazly S, El-Bohi K, Abdelazeez A, Kehelo K, Kim H, Muzandu K, Ishizuka M, Kazusaka A, Fujita S. (2005). AhR and PPARalpha: Antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11. Xenobiotica 35:51–68.
   PubMed Web of Science ®Google Scholar
• Sher T, Yi H, McBride O, Gonzalez F. (1993). cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32:5598–5604.
   PubMed Web of Science ®Google Scholar
• Shipley J, Waxman D. (2004). Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b. Toxicol Appl Pharmacol 199:275–284.
   PubMedGoogle Scholar
• Sofuni T, Matsuoka A, Sawada M, Ishidate M Jr., Zeiger E, Shelby M. (1990). A comparison of chromosome aberration induction by 25 compounds tested by two Chinese hamster cell (CHL and CHO) systems in culture. Mutat Res 241:175–213.
   PubMedGoogle Scholar
• Spitzer C, Marquardt F. (1973). Irgasan DP-300 hexachlorophene content of plasma samples from the Hill Top Research Inc. 21 days hand washing study. Ciba-Geigy Corporation.
   Google Scholar
• Stankowski L Jr. (1993). Ames/Salmonella plate incorporation assay on test article 39316 (CC no. 14663-09)—Amended final report. Pharmakon study no. 301-CP-001-93.
   Google Scholar
• Steinkjer B, Braathen L. (1988). Contact dermatitis from triclosan (Irgasan DP 300). Contact Dermatitis 18:243–244.
   PubMed Web of Science ®Google Scholar
• Stierlin H. (1972a). Study of pharmacokinetics and metabolism in mouse, rat, rabbit and dog. Ciba-Geigy Limited. Report no. 33. December 1.
   Google Scholar
• Stierlin H. (1972b). Exploratory study of the percutaneous absorption of GP 41 353 in man following topical application in a cream base. Ciba-Geigy Limited. Report no. 34. November 23.
   Google Scholar
• Stierlin H, Mucke W. (1976). GP 41 353: Investigations of percutaneous absorption in the rat and the rabbit. Ciba-Geigy Limited.
   Google Scholar
• Stierlin H, Murbach R, Theobald W. (1976). GP 41 353: Triclosan: Pharmacokinetic and metabolic studies in man following oral administration of the 14C-labelled preparation. Ciba-Geigy Limited.
   Google Scholar
• Strasser F, Muller D. (1973). Chromosome studies in somatic cells—GP 41 353 (Triclosan) Chinese hamster (test for mutagenic effects on bone marrow cells). Ciba-Geigy Limited. April 16.
   Google Scholar
• Strasser F, Muller D. (1978). Point mutation assay with mouse lymphoma cells I. In vitro test II. Host-mediated assay with FAT 80 023 A (test for mutagenic properties in mammalian cells). Ciba-Geigy Limited. Experiment nos. 78-2305 and 78-2306. May 10.
   Google Scholar
• Strasser F, Muller D. (1979). Chromosome studies in somatic cells long-term study with FAT 80 023 A. Chinese hamster (test for mutagenic effects on bone marrow cells). Ciba-Geigy Limited. Experiment no. 78-3105. Batch 652. February 15.
   Google Scholar
• Tharappel J, Cunningham M, Spear B, Glauert H. (2001). Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators WY-14,643, gemfibrozil, and dibutyl phthalate. Toxicol Sci 62:20–27.
   PubMedGoogle Scholar
• Thevenaz P. (1987). 28-Day toxicity studying mice (administration in feed) with special reference to histopathology. Final report. Ciba-Geigy Limited. GU project number 864005. April 10.
   Google Scholar
• Thomann P, Maurer T. (1978) Experiments in guinea pigs with Irgasan DP300.
   Google Scholar
• Thomas E. (1994). The effect of FAT 80′023/R and the model inducers phenobarbitone, 3-methylcholanthrene, pregnenolone-16α-carbonitrile and napenopin on selected biochemical and morphological liver parameters in the Syrian hamster. Ciba-Geigy Limited. Laboratory report no. CB 93/40.
   Google Scholar
• Thompson T. (1975). Triclosan—Results to date of multiple scrub studies with GP 41353 surgical scrub. Personal Communication to Dr. George Lukas.
   Google Scholar
• Thompson T, Goodblatt R, Borman C. (1975a). Triclosan (Report 1): A method for determining triclosan in human plasma and urine, and results of a pilot hand washing study. Ciba-Geigy Corporation.
   Google Scholar
• Thompson T, Borman C, Goodblatt R. (1975b). Triclosan (Report 2): Concentration in human plasma and urinary excretion after dermal application of GP 41353 patient skin prep. Ciba-Geigy Corporation.
   Google Scholar
• Thompson T, Goodblatt R, Borman C. (1976). Triclosan (Report 3): Concentration in Human plasma and urinary excretion after use of GP 41353 surgical scrub. Ciba-Geigy Corporation.
   Google Scholar
• Trimmer G. (1994). 90-Day subchronic dermal toxicity study in the rat with satellite group with Irgasan DP300 (MRD-92-399). Ciba-Geigy Limited. Exxon Biomedical Sciences, Inc. Toxicology Laboratory. Laboratory project ID 139910B.
   Google Scholar
• Trutter J. (1993). 13-Week subchronic oral toxicity study of tricolsan in CD-1 mice. Hazleton Washington Inc. Report no. HWA 483-287.
   Google Scholar
• Tucker M, Orton T. (1995). Comparative Toxicology of Hypolipidemic Fibrates. Bristol, PA: Taylor and Francis (as cited in IARC, 1995).
   Google Scholar
• Tweats D, Scott A, Westmoreland C, Carmichael P. (2007). Determination of genetic toxicity and potential carcinogenicity in vitro—Challenges post the Seventh Amendment to the European Cosmetics Directive. Mutagenesis 22:5–13.
   PubMed Web of Science ®Google Scholar
• Ullmann L. (1980). Report on eye irritation in the rabbit after single application of FAT 80 023/A. Ciba-Geigy Limited. Sponsored by Dyestuffs and Chemicals Division. Project number 801012.
   Google Scholar
• Urbach F. (1973). Phototoxicity study in mice pigs and humans. Philadelphia: Temple University Skin and Cancer Hospital.
   Google Scholar
• USEPA. (1987). Methods for Assessing Exposure to Chemical Substances. Volume 7: Methods for Assessing Consumer Exposure to Chemical Substances. Exposure Evaluation Division. EPA 560/5-85-007.
   Google Scholar
• USEPA. (1997). Exposure Factors Handbook. Office of Research and Development. EPA.600/P-95/002F. Washington DC: EPA.
   Google Scholar
• USEPA. (2000). Benchmark Dose technical guidance document. EPA/630/R-00/001.
   Google Scholar
• USEPA. (2003). Proposed OPPTS Science Policy: PPARalpha-mediated hepatocarcinogenesis in rodents and relevance to human health risk assessments. P. T. S. Office of Prevention.
   Google Scholar
• USEPA. (2005). Guidelines for carcinogen risk assessment. EPA/630/P-03/001b.
   Google Scholar
• USEPA. (2007). BMDS Version 2.0 Beta Benchmark Dose software. Washington, DC: National Center for Environmental Assessment. Office of Research and Development. Available at: http://www.epa.gov/ncea/bmds. Accessed January 8, 2008.
   Google Scholar
• USEPA. (2008). 5-Chloro-2-(24-dichlorophenoxy)phenol (Triclosan): Toxicology chapter for the Reregistration Eligibility Decision (RED) document. Case no. 2340. Office of Prevention Pesticides & Toxic Substances.
   Google Scholar
• Van Dijk A. (1994). 14C-Triclosan: Absorption, distribution, metabolism and elimination after single/repeated oral and intravenous administration to hamsters. RCC Umweltchemie AG. RCC project 351707. November 11.
   Google Scholar
• Van Dijk A. (1995). 14C-Triclosan: Absorption, distribution, metabolism and elimination after single/repeated oral and intravenous administration to mice. RCC Umweltchemie AG. RCC project 337781. March 1.
   Google Scholar
• Van Dijk A. (1996). 14C-Triclosan: Absorption, distribution and excretion (ADE) after single/repeated oral and repeated oral administration to male rats. RCC Umweltchemie AG. RCC project 341998.
   Google Scholar
• Veronesi S, de Padova M, Vanni D, Melino M. (1986). Contact dermatitis to triclosan. Contact Dermatitis 15:257–258.
   PubMedGoogle Scholar
• Volkner W. (1991). Chromosome aberration assay in bone marrow cells of the rat with FAT 80′023/Q. Cytotest Cell Research. CCR project no. 218305/1991. April 23.
   Google Scholar
• Wahlberg J. (1976). Routine patch testing with Irgasan DP 300. Contact Dermatitis 2:292.
   PubMedGoogle Scholar
• Watkinson A. (1998a). In vitro human skin penetration and distribution of 14C-labelled triclosan from a w/o emulsion. Ciba Specialty Chemicals Inc. CSC/4e1/98.
   Google Scholar
• Watkinson A. (1998b). In vitro human skin penetration and distribution of 14C-labelled triclosan from a dishwashing liquid. Ciba Specialty Chemicals, Inc. CSC/4e2/98.
   Google Scholar
• Watkinson A. (1998c). In vitro human skin penetration and distribution of 14C-labelled triclosan from a deodorant formulation. Ciba Specialty Chemicals Inc. CSC/4e3/98.
   Google Scholar
• Watkinson A. (1998d). In vitro human skin penetration and distribution of 14C-labelled triclosan from a soap solution. Ciba Specialty Chemicals Inc. CSC/4e4/98.
   Google Scholar
• Weegels M, van Veen M. (2001). Variation of consumer contact with household products: A preliminary investigation. Risk Anal 21:499–511.
   PubMed Web of Science ®Google Scholar
• Wennersten G, Thune P, Brodthagen H, Jansen C, Rystedt I. (1984). The Scandinavian multicenter photo patch study. Preliminary results. Contact Dermatitis 10:305–309.
   Google Scholar
• Wnorowski G. (1994). Dermal sensitization test—Buehler method for triclosan (Irgasan DP 300), lot no. 5.2.0211.0. Conducted by Product Safety Labs. Ciba-Geigy Limited. Laboratory number 2635.
   Google Scholar
• Wolff M, Teitelbaum S, Windham G, Pinney S, Britton J, Chelimo C, Godbold J, Biro F, Kushi L, Pfeiffer C, Calafat A. (2007). Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect 115:116–121.
   PubMed Web of Science ®Google Scholar
• Woods CG, Burns AM, Bradford BU, Ross PK, Kosyk O, Swenberg JA, Cunningham ML, Rusyn I. (2007). WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase. Toxicol Sci 98:366–374.
   PubMedGoogle Scholar
• Woodyatt N, Lambe K, Myers K, Tugwood J, Roberts R. (1999). The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: Significance for species differences in response to PPs. Carcinogenesis 20:369–372.
   PubMed Web of Science ®Google Scholar
• Yau E, Green J. (1986). FAT 80′023 2-year oral administration to rats (MIN 833005). Ciba-Geigy Limited. April 28.
   Google Scholar
• Zafar A, Butler R, Reese D, Gaydos L, Mennonna P. (1995). Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 23:200–208.
   PubMed Web of Science ®Google Scholar
• Zangar R, Woodcroft K, Kocarek T, Novak R. (1995). Xenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes. Drug Metab Dispos 23:681–687.
   PubMed Web of Science ®Google Scholar
• Zangar R, Woodcroft K, Novak R. (1996). Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression. Toxicol Appl Pharmacol 141:110–116.
   Google Scholar
• Zorrilla LM, Gibson EK, Jeffay SC, Crofton KM, Setzer WR, Cooper RL, Stoker TE. (2009). The effects of triclosan on puberty and thyroid hormones in male Wistar rats. Toxicol Sci 107: 56–64.
   PubMed Web of Science ®Google Scholar